Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apollomics Inc. - Class A Ordinary Shares (NQ: APLM ) 0.1140 -0.0050 (-4.20%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 808,789 Open 0.1190 Bid (Size) 0.1149 (50) Ask (Size) 0.1150 (77) Prev. Close 0.1190 Today's Range 0.1122 - 0.1199 52wk Range 0.1053 - 1.790 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Monday's After-Market Session September 30, 2024 Via Benzinga Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024 September 16, 2024 Vebreltinib is efficacious in both treatment naïve and previously treated patients with NSCLC with METex14 skipping, and regardless of co-occurring MET amplification From Apollomics Inc. Via GlobeNewswire Performance YTD -87.60% -87.60% 1 Month -22.55% -22.55% 3 Month -28.48% -28.48% 6 Month -72.85% -72.85% 1 Year -86.07% -86.07% More News Read More Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Apollomics Inc. Via GlobeNewswire What's Going On With Apollomics (APLM) Stock Exploding Higher? July 17, 2024 Via Benzinga Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress August 14, 2024 From Apollomics Inc. Via GlobeNewswire S&P 500 Gains 1%; Home Depot Earnings Top Views August 13, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Penny Stock Apollomics Trading Higher On Tuesday? August 13, 2024 Via Benzinga Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July August 13, 2024 Via Benzinga Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial August 13, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference August 08, 2024 From Apollomics Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 18, 2024 Via InvestorPlace Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket July 18, 2024 Via Benzinga Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement July 16, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Announces Updated Strategic Focus and Leadership Team Changes July 03, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting June 04, 2024 From Apollomics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session May 29, 2024 Via Benzinga Apollomics Announces Presentation at the 2024 BIO International Convention May 29, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Announces Private Placement Financing and Addition to Board of Directors May 08, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene April 25, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting April 10, 2024 From Apollomics Inc. Via GlobeNewswire Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting April 02, 2024 From Apollomics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 01, 2024 Via Benzinga Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results March 28, 2024 From Apollomics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session March 26, 2024 Via Benzinga Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024 March 26, 2024 From Apollomics Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
